COMPANY PROFILE

Avidia

Explore full profile

Mountain View, United StatesFounded 2003Biotech & Life Sciences

Valuation $250–500M Last recorded · 2006

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Avidia

Established in 2001, Momentum Technology Partners (MTP) was formed by executive level entrepreneurs who have years of experience in launching companies, products and services. From startups and early-stage organizations to Fortune 500 enterprises, we know how to quickly determine the appropriate markets for your business; assess the competitive landscape; formulate the most targeted sales, market and product strategies to develop immediate tangible results. Whether your needs center on a complete turnkey and or augment for sales, market creation/development, strategic capital resources or developing new product or market feasibility studies, our strategic insight, operations acumen, and sales and market experience enable us to deliver value that will exceed your expectations.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2003
Headquarters: Mountain View, United States
Employees: 1
Open positions: None listed
Dealroom signal: 55.6/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITIONOther financing	Oct 2006	$380M	$380M	Amgen	—
SERIES COther financing	May 2006	$44M	$175M	Alloy Ventures · Skyline Ventures · HealthCare Ventures · MedImmune Ventures	—

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Avidia website traffic

Latest recorded traffic for Avidia is 240 monthly website visits, up 200% over the last three months. Avidia's team declined 75% over the past year.

Latest monthly visits240 3-month web change+200% 1-year team growth-75%

Monthly website visitsApr 2016–May 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
VOVodorasloYour solution to better air quality	Sofia, Bulgaria	Operational	1	$61K	$132K
NBNormax BiomedNormax focus for 2022 is rapid growth in mRNA Vaccine R&D and manufacturing for sustainable pandemic preparedness	Cork, Ireland	Operational
ETENSEM TherapeuticsBiotechnology company focusing on high value and difficult-to-drug oncology targets	Medford, United States	Operational
LTLTZ TherapeuticsDevelops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need	Redwood City, United States	Operational
ATAtG TherapeuticsAt AtG, we develop novel classes of medicines and biomarkers to prevent cancer therapeutic resistance	L'Hospitalet de Llobregat, Spain	Operational
TTTeitur TrophicsCyclic peptide therapeutics for neurodegenerative diseases	Aarhus, Denmark	Operational
RPRivus PharmaceuticalsOperates as a biopharmaceutical company dedicated to improving cardio-metabolic health	Charlottesville, United States	Operational
KTKintsugi TherapeuticsDevelopment of ER stress inhibitors for the treatment of metabolic diseases	Barcelona, Spain	Operational